Ligand validation:6ZOC

ERY: ERYTHROMYCIN A

ERY is a Ligand Of Interest in 6ZOC designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZOC_ERY_A_1203	20%	34%	0.266	0.873	0.98	1.6	1	15	1	0	100%	0.75
3AOC_ERY_C_3402	11%	33%	0.329	0.855	1.01	1.64	1	18	5	0	100%	0.7
4ZJL_ERY_D_1101	0%	22%	1.068	0.749	1.27	1.95	2	20	8	0	100%	0.82
4ZJO_ERY_A_1101	0%	21%	1.121	0.798	1.27	2.01	5	24	5	0	100%	0.86
3FRQ_ERY_A_195	93%	23%	0.067	0.96	1.55	1.65	7	18	1	0	100%	1
5IGY_ERY_A_403	90%	4%	0.073	0.954	3.77	1.96	29	26	0	0	100%	1
5IWU_ERY_A_404	89%	4%	0.068	0.946	3.92	1.94	31	26	0	0	100%	1
4M83_ERY_A_1400	87%	36%	0.083	0.954	1.25	1.26	6	6	0	0	100%	5
5IH0_ERY_A_404	86%	24%	0.086	0.953	1.73	1.37	14	12	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.